Healthy Inc > Blog > Esomeprazole manufacturer Mumbai
Posted on:

What is esomeprazole Domperidone capsules used for?

Pharmaceutical Product Monograph: Esomeprazole & Domperidone FDC

In the pharmaceutical industry, the combination of Esomeprazole and Domperidone is one of the most widely prescribed Fixed-Dose Combinations (FDCs) for upper gastrointestinal disorders. As a pharmacist and manufacturer, I classify this as a “Synergistic Acid-Prokinetic” therapy. It is technically superior to a single PPI because it addresses both the chemical (acid) and mechanical (movement) failures of the digestive system.

At your WHO-GMP facility in Mumbai, this Sustained-Release (SR) capsule is a flagship SKU for Gastroenterology portfolios. It is specifically designed to overcome “Refractory GERD”—where acid suppression alone isn’t enough to stop symptoms.

Therapeutic Profile: Primary Indications

This combination is indicated for acid-peptic disorders complicated by nausea or slow stomach emptying.

ComponentTechnical RoleClinical Indication
Esomeprazole (40 mg)PPI (Proton Pump Inhibitor)Heals esophagitis, reduces heartburn, and prevents gastric ulcers.
Domperidone (30 mg SR)Dopamine ($D_2$) AntagonistReduces nausea, prevents vomiting, and speeds up gastric emptying.

Combined Use: It is the “Gold Standard” for Gastroesophageal Reflux Disease (GERD) accompanied by bloating, fullness, or “nausea after eating.”

Mechanism: The “One-Two Punch”

The two drugs work together to normalize the flow of the GI tract:

  1. Acid Suppression (Esomeprazole): It technically inhibits the $H^+/K^+$-ATPase enzyme system in the stomach lining. This stops the “acid burn” that causes pain and tissue damage.

  2. Motility Enhancement (Domperidone): It blocks $D_2$ receptors in the gut and the “Chemoreceptor Trigger Zone” (CTZ) of the brain.

  3. The Synergy: Domperidone technically increases the pressure of the Lower Esophageal Sphincter (LES)—acting like a “valve tightener”—while simultaneously moving food out of the stomach faster. This ensures that the suppressed acid (from the Esomeprazole) stays down where it belongs.

The Pharmacist’s “Technical Warning”

  • The “30-Minute” Rule: To ensure the prokinetic effect is ready when food arrives, these capsules must be taken on an empty stomach, strictly 30 minutes before a meal.

  • Cardiac Precaution: Domperidone can technically cause QT Prolongation (heart rhythm issues) at high doses or when combined with certain antibiotics (like Erythromycin). This is a critical screening point for elderly patients.

  • Hormonal Changes: Chronic use of Domperidone can increase Prolactin levels, which may lead to breast tenderness or menstrual irregularities.

  • No Crushing: The pellets inside the capsule are Sustained-Release (SR). Chewing them causes “Dose Dumping,” which spikes blood levels and increases side-effect risks.

The Manufacturer’s Perspective: Technical & Export

From the CEO’s desk at Healthy Life Pharma / Healthy Inc:

  • The “SR” Pelletization USP: On your digital marketplace, highlight that your capsules use Dual-Pellet Technology.

    • Esomeprazole Pellets: Enteric-coated to survive stomach acid.

    • Domperidone Pellets: Sustained-release to provide 24-hour motility support.

  • The “Refractory GERD” Market: Position this FDC for the “Failed PPI” segment. Many patients on your website will be looking for something “stronger” than basic Pantoprazole. This combination is the technical answer.

  • Stability & Packaging: Esomeprazole is extremely moisture-sensitive. At our plant, we use Alu-Alu blistering to protect the integrity of the pellets. Standard PVC/PVDC is a technical failure for Zone IVb (tropical) exports.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Esomeprazole 40 mg + Domperidone 30 mg SR to support your registration in international B2B gastro tenders.

Posted on:

What is the use of esomeprazole capsules?

Pharmaceutical Product Monograph: Esomeprazole Delayed-Release Capsules

In the pharmaceutical industry, Esomeprazole is a high-potency Proton Pump Inhibitor (PPI). As a pharmacist and manufacturer, I classify this as the “S-isomer” of Omeprazole. It is technically superior to its predecessor because it provides more predictable plasma levels and longer-lasting acid suppression, making it a “Gold Standard” for acid-peptic disorders in 2026.

 

At your WHO-GMP facility in Mumbai, Esomeprazole (20 mg & 40 mg) is a core SKU. Its formulation as a Multiple-Unit Pellet System (MUPS) inside the capsule is a technical hallmark of high-quality manufacturing.

 

Therapeutic Profile: Primary Indications

Esomeprazole is indicated for conditions where reducing gastric acid is essential for healing and symptom relief.

 

IndicationClinical ContextTechnical Rationale
Gastroesophageal Reflux (GERD)GastroenterologyTreats “heartburn” and prevents acid from damaging the esophageal lining.
Erosive Esophagitis (EE)GastroenterologyHeals physical “burns” or ulcers in the esophagus caused by chronic acid reflux.
H. pylori EradicationInfectious DiseasePart of “Triple Therapy” (with Amoxicillin & Clarithromycin) to cure stomach ulcers.
NSAID-Associated UlcersRheumatologyPrevents stomach damage in patients taking long-term painkillers like Ibuprofen or Aspirin.
Zollinger-Ellison SyndromeEndocrinologyManages rare conditions where the stomach produces extreme, pathological amounts of acid.

Mechanism: The Irreversible Proton Pump Block

Esomeprazole works by shutting down the “acid taps” of the stomach:

 

  1. Concentration in Parietal Cells: The drug technically travels through the bloodstream and concentrates in the acidic environment of the stomach’s parietal cells.

  2. Conversion to Active Form: In this acidic space, it is converted into a reactive “sulfenamide.”

  3. H+/K+-ATPase Inhibition: It binds irreversibly to the “proton pump” enzyme. Because the bond is covalent, the cell must manufacture entirely new enzymes to produce acid again.

     

  4. 24-Hour Coverage: This irreversible block is why a single 20 mg or 40 mg capsule can technically suppress acid for over 24 hours, even though the drug’s half-life in the blood is only about 1.5 hours.

The Pharmacist’s “Technical Warning”

  • The “One-Hour” Rule: For maximum efficacy, it must be taken at least one hour before a meal (usually breakfast). Taking it with food can technically reduce absorption by up to 50%.

     

  • No Crushing: The granules inside the capsule are Enteric-Coated (EC). Crushing or chewing them destroys the coating, causing the stomach acid to neutralize the drug before it can work.

     

  • The “Bone & Mineral” Risk: Long-term daily use (over 1 year) can technically lead to hypomagnesemia and an increased risk of bone fractures due to reduced calcium absorption.

     

  • C. diff Warning: By raising stomach pH, Esomeprazole may allow Clostridioides difficile bacteria to thrive, potentially causing severe diarrhea.

The Manufacturer’s Perspective: Technical & Export

From the CEO’s desk at Healthy Life Pharma / Healthy Inc:

  • The “MUPS” Technology: On your digital marketplace, highlight that your capsules contain stabilized Enteric-Coated Pellets. This “Multiple-Unit Pellet System” is a premium technical feature that ensures uniform drug release and prevents “dose dumping.”

     

  • The “NSAID Protection” Market: Position this as a co-prescription for your Orthopedic range. Every B2B order for chronic NSAIDs should be paired with Esomeprazole to ensure patient safety and stomach protection.

  • Stability & Packaging: Esomeprazole is extremely acid-labile and moisture-sensitive. At our Mumbai plant, we strictly use Alu-Alu blistering. Standard PVC/PVDC is often insufficient for Zone IVb (tropical) exports, as moisture can degrade the pellets and turn them brown.

     

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Esomeprazole 20 mg and 40 mg to support your registration in international B2B gastro tenders.

Posted on:

What is esomeprazole and Levosulpiride used for?

Pharmaceutical Product Monograph: Esomeprazole & Levosulpiride FDC

In the pharmaceutical industry, the combination of Esomeprazole and Levosulpiride is a high-demand Fixed-Dose Combination (FDC). As a pharmacist and manufacturer, I classify this as a “Dual-Action Gastro-Prokinetic.” It is technically superior to simple antacids because it treats both the chemical (acid) and mechanical (motility) causes of digestive distress.

At your WHO-GMP facility in Mumbai, this Sustained-Release (SR) capsule is a “best-seller” for Gastroenterology portfolios, particularly for patients with “Functional Dyspepsia” who do not respond to PPIs alone.

Therapeutic Profile: Primary Indications

This combination is indicated for complex acid-peptic disorders where stomach emptying is delayed.

ComponentTechnical RoleClinical Indication
Esomeprazole (40 mg)PPI (Proton Pump Inhibitor)GERD, Heartburn, Gastric Ulcers, and Zollinger-Ellison Syndrome.
Levosulpiride (75 mg SR)Prokinetic / $D_2$ AntagonistFunctional Dyspepsia, Diabetic Gastroparesis, and Irritable Bowel Syndrome (IBS).

Combined Use: It is specifically used for Gastroesophageal Reflux Disease (GERD) that is resistant to standard therapy, as well as chronic bloating and “fullness” after meals.

Mechanism: The “Chemical-Mechanical” Synergy

The two drugs work in tandem to normalize the environment of the upper GI tract:

  1. Acid Suppression (Esomeprazole): It technically inhibits the $H^+/K^+$-ATPase enzyme system (the “proton pump”) at the secretory surface of the gastric parietal cell. This provides long-lasting reduction of gastric acid.

  2. Motility Enhancement (Levosulpiride): It is a selective antagonist of central and peripheral dopamine $D_2$ receptors. By blocking dopamine, it increases the release of acetylcholine.

  3. The Result: This technically increases the tone of the Lower Esophageal Sphincter (preventing acid from rising) and speeds up Gastric Emptying (moving food out of the stomach faster).

The Pharmacist’s “Technical Warning”

  • The “Morning” Rule: To ensure maximum bioavailability, these capsules must be taken on an empty stomach, preferably 30–60 minutes before breakfast.

  • Extrapyramidal Symptoms (EPS): Because Levosulpiride crosses the blood-brain barrier, it can technically cause tremors or “restless legs” in some patients. This is rare but must be monitored.

  • Hormonal Shifts: Levosulpiride can increase Prolactin levels, which may lead to breast tenderness or menstrual irregularities in some users.

  • Bone Health: Long-term use of Esomeprazole (over 1 year) can technically reduce calcium absorption, increasing the risk of fractures in geriatric patients.

The Manufacturer’s Perspective: Technical & Export

From the CEO’s desk at Healthy Life Pharma / Healthy Inc:

  • The “SR” Technology: At our Mumbai plant, we focus on the Sustained Release (SR) formulation of Levosulpiride. This is technically superior because it provides a steady 24-hour prokinetic effect with a single daily dose, significantly improving patient compliance.

  • The “Refractory GERD” Market: On your digital marketplace, position this FDC for patients who “fail” on Omeperazole or Pantoprazole alone. This “Specialized GI” niche is highly profitable for B2B export to private hospital chains.

  • Stability & Packaging: Esomeprazole is highly acid-labile. We ensure our capsules use Enteric-Coated (EC) Pellets. Use Alu-Alu blistering to prevent moisture ingress, which can degrade the pellets and lead to “Product Inefficacy” claims in tropical export zones.

  • Dossier Support: We provide full WHO-standard CTD/eCTD Dossiers for Esomeprazole 40 mg + Levosulpiride 75 mg SR to support your registration in international B2B tenders.

Add to cart